Why the study?
Cancer and cardiovascular disease commonly coexist, with long-term cancer survivors facing higher CVD mortality than the general population, requiring multidisciplinary care pathways and effective risk management.
Effective management of coexisting cancer and cardiovascular disease requires multidisciplinary care models, care pathways, and accessible risk assessment tools.
Answers are grounded in this paper and cite their sources.
Supports early CVD monitoring in cancer survivors; leaves open optimal multidisciplinary pathway designs.
Cancer and cardiovascular disease (CVD) commonly coexist, with increasing evidence that long-term cancer survivors are more likely to die from CVD than the general population. Effective management of CVD and its risk factors requires identification of patients at increased risk who may benefit from early intervention and their appropriate monitoring across the disease trajectory. Improving outcomes requires new models of multidisciplinary cancer care supported by care pathways. Such pathways require a clear delineation of the roles and responsibilities of all team members and provision of appropriate enablers for their delivery. These include accessible point-of-care tools/risk calculators, patient resources, and the provision of tailored training opportunities for health care providers.
No takes yet. Share an insight, caveat, or question.
Sverdlov et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: